Bio

Kirsten Lund brings over 15 years of finance experience to the company and has held the position of Group Finance Director from November 2019 after three years as Group Financial Controller. Kirsten has supported the CFO, led the finance teams in both the UK and US, and advised the Board on all financial matters relating to the Group.

Starting January 2022 Kirsten has transitioned into the position of EMEA Director and works closely with the management team to help drive forward the strategy of the business into new markets. Utilising the knowledge acquired over the years in the healthcare sector, Kirsten provides invaluable experience and understanding around the Company structure and routes to market.

Kirsten received her Bachelor of Science degree from the University of Derby and successfully completed the ACCA qualification after joining Tissue Regenix in 2010, qualifying in 2015.